Related Experiment Videos
DNA adducts in model systems and humans
K W Turteltaub1, C E Frantz, M R Creek
1Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, CA 94550.
Journal of Cellular Biochemistry. Supplement
|January 1, 1993
Summary
DNA adducts, markers of chemical carcinogen exposure, decrease linearly with dose. Tissue-specific adduct levels and species differences impact their role in human cancer etiology, necessitating further research for biomarker development.
Area of Science:
- Toxicology and Carcinogenesis
- Molecular Biology
- Biochemistry
Background:
- Chemically induced cancer is linked to DNA adducts, which are formed by carcinogen-DNA binding.
- The role of DNA adducts in human cancer etiology remains unclear due to challenges in detecting adducts at low, human-relevant exposure levels.
- Understanding the relationship between adducts and biological effects at low doses is critical.
Purpose of the Study:
- To assess DNA damage from heterocyclic amine carcinogens in the diet.
- To investigate the dose-response relationship of DNA adduction in rodents at low exposure levels.
- To explore tissue-specific adduction and species differences in carcinogen metabolism.
Main Methods:
- Utilized 32P-postlabeling technique.
- Employed accelerator mass spectrometry for sensitive adduct detection.
- Compared carcinogen metabolism routes between rodents and humans.
Main Results:
- DNA adduction in rodents decreased linearly with decreasing carcinogen dose, aligning with human exposure levels.
- Adduct levels were dose-correlated within tissues but showed tissue-specific patterns.
- Tumor site did not consistently correlate with adduct levels, suggesting varying adduct formation/repair rates.
Conclusions:
- DNA adduct levels decrease linearly with dose, but tissue specificity and species differences complicate direct correlation with human cancer risk.
- Further research using model systems is needed to understand dosimetry, species variations, and the role of adducts in mutagenesis.
- Adducts hold potential as biomarkers for estimating carcinogen exposure and individual susceptibility once their significance in human disease is better understood.